May 6, 2020 / 10:32 PM / 2 months ago

BRIEF-Orasure Technologies Reports Q1 Rev Of $31.6 Million

May 6 (Reuters) - OraSure Technologies Inc:

* ORASURE ANNOUNCES 2020 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES COVID-19 UPDATE

* Q1 REVENUE ROSE 5 PERCENT TO $31.6 MILLION

* DEVELOPING ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETECTION OF HUMAN ANTI-SARS-COV-2 ANTIBODIES IN ORAL FLUID SPECIMENS

* EXPECTS TO FILE FOR FDA EUA FOR ELISA TEST IN JUNE 2020

* WITHDRAWING ITS PREVIOUSLY ANNOUNCED FULL-YEAR 2020 FINANCIAL GUIDANCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below